Literature DB >> 11332665

Severe, rapidly progressive human immunodeficiency virus type 1 disease in newborns with coinfections.

T Pillay1, M Adhikari, J Mokili, D Moodley, C Connolly, T Doorasamy, H M Coovadia.   

Abstract

AIM: To describe a severe form of rapidly progressive HIV-1 infection manifesting in the neonatal period.
METHOD: Prospective cohort study, King Edward VIII Hospital, Durban, South Africa. HIV-1-exposed neonates with hepatosplenomegaly, lymphadenopathy or persistent pneumonia within the first 28 days of life were investigated for perinatal infections. Confirmation of neonatal HIV-1 infection, HIV-1 subtype and clinical outcomes were studied.
RESULTS: Twenty-three (72%) of 32 symptomatic HIV-1-exposed neonates recruited at a mean of 15.2 days were HIV-1-infected. HIV-1 infection was detected in 5 patients who were tested within 48 h of birth, confirming congenital infection. Congenital infection was not excluded in any case. Median neonatal viral load at recruitment was 471,932 copies/ml and median CD4 was 777 cells/mm3. The predominant clinical presentation was growth retardation and prematurity. Perinatal infections detected included: tuberculosis (8), syphilis (6) and cytomegalovirus (10). All of the neonates with perinatal tuberculosis were HIV-1-coinfected. Maternal and neonatal viral load and CD4 at recruitment were not statistically different between the groups with tuberculosis vs. other coinfections. Gag gene sequence analysis confirmed closely aligned HIV-1 subtype C in mothers and neonates. Nineteen (83%) died by 9 months, with a mean age at death of 3.5 months.
CONCLUSIONS: A distinct group of HIV-1-infected babies may clinically manifest in the neonatal period with perinatal coinfections, subsequent rapidly progressive HIV-1 and early death.

Entities:  

Mesh:

Year:  2001        PMID: 11332665     DOI: 10.1097/00006454-200104000-00007

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  6 in total

Review 1.  Neonatal pneumonia in developing countries.

Authors:  T Duke
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-05       Impact factor: 5.747

2.  Challenges of Childhood TB/HIV Management in Malawi.

Authors:  G Poerksen; Pn Kazembe; Sm Graham
Journal:  Malawi Med J       Date:  2007-12       Impact factor: 0.875

Review 3.  PEPFAR scale-up of pediatric HIV services: innovations, achievements, and challenges.

Authors:  Elaine J Abrams; R J Simonds; Surbhi Modi; Emilia Rivadeneira; Paula Vaz; Chipepo Kankasa; Denis Tindyebwa; B Ryan Phelps; Sara Bowsky; Chloe A Teasdale; Emilia Koumans; Andrea J Ruff
Journal:  J Acquir Immune Defic Syndr       Date:  2012-08-15       Impact factor: 3.731

4.  Predictors of successful early infant diagnosis of HIV in a rural district hospital in Zambézia, Mozambique.

Authors:  Rebecca E Cook; Philip J Ciampa; Mohsin Sidat; Meridith Blevins; Janeen Burlison; Mario A Davidson; Jorge A Arroz; Alfredo E Vergara; Sten H Vermund; Troy D Moon
Journal:  J Acquir Immune Defic Syndr       Date:  2011-04       Impact factor: 3.771

5.  HIV-Associated Tuberculosis in the Newborn and Young Infant.

Authors:  M Adhikari; P Jeena; R Bobat; M Archary; K Naidoo; A Coutsoudis; R Singh; N Nair
Journal:  Int J Pediatr       Date:  2011-04-04

6.  Use of the Xpert(®) MTB/RIF assay for diagnosing pulmonary tuberculosis comorbidity and multidrug-resistant TB in obstetrics and gynaecology inpatient wards at the University Teaching Hospital, Lusaka, Zambia.

Authors:  Matthew Bates; Yusuf Ahmed; Lophina Chilukutu; John Tembo; Busiku Cheelo; Sylvester Sinyangwe; Nathan Kapata; Markus Maeurer; Justin O'Grady; Peter Mwaba; Alimuddin Zumla
Journal:  Trop Med Int Health       Date:  2013-07-03       Impact factor: 2.622

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.